PR Newswire
LONDON, United Kingdom, May 03
The Biotech Growth Trust PLC
(the "Company")
Compliance with Market Abuse Regulation
3 May 2024
The Company confirms that:
a) all inside information which the Directors and Company may have had has been notified to a Regulated Information Service ("RIS");
b) the Company's net asset value per share is calculated and announced through a RIS on a daily basis;
c) the Company has no reason to believe that there will be any material difference between the net asset value per share as at close of business on Thursday, 28 March 2024, which was announced on Tuesday, 2 April 2024, and the financial information to be published in the announcement of its results for the year ended 31 March 2024.
The Company is, therefore, not prohibited from dealing in its own securities during the closed period, as defined by the UK Market Abuse Regulation, which will end on the date of the publication of its results for the year ended 31 March 2024, expected to be on or after Wednesday, 5 June 2024.
-ENDS-
For further information please contact:
Katherine Manson Frostrow Capital LLP - 0203 709 8734
Hinweis: ARIVA.DE veröffentlicht in dieser Rubrik Analysen, Kolumnen und Nachrichten aus verschiedenen Quellen. Die ARIVA.DE AG ist nicht verantwortlich für Inhalte, die erkennbar von Dritten in den „News“-Bereich dieser Webseite eingestellt worden sind, und macht sich diese nicht zu Eigen. Diese Inhalte sind insbesondere durch eine entsprechende „von“-Kennzeichnung unterhalb der Artikelüberschrift und/oder durch den Link „Um den vollständigen Artikel zu lesen, klicken Sie bitte hier.“ erkennbar; verantwortlich für diese Inhalte ist allein der genannte Dritte.